Correlation Between Cyclacel Pharmaceuticals and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Cyclacel Pharmaceuticals and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyclacel Pharmaceuticals and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyclacel Pharmaceuticals and SAB Biotherapeutics, you can compare the effects of market volatilities on Cyclacel Pharmaceuticals and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyclacel Pharmaceuticals with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyclacel Pharmaceuticals and SAB Biotherapeutics.
Diversification Opportunities for Cyclacel Pharmaceuticals and SAB Biotherapeutics
-0.6 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cyclacel and SAB is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Cyclacel Pharmaceuticals and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Cyclacel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyclacel Pharmaceuticals are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Cyclacel Pharmaceuticals i.e., Cyclacel Pharmaceuticals and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Cyclacel Pharmaceuticals and SAB Biotherapeutics
Given the investment horizon of 90 days Cyclacel Pharmaceuticals is expected to under-perform the SAB Biotherapeutics. In addition to that, Cyclacel Pharmaceuticals is 1.02 times more volatile than SAB Biotherapeutics. It trades about -0.05 of its total potential returns per unit of risk. SAB Biotherapeutics is currently generating about 0.0 per unit of volatility. If you would invest 1,070 in SAB Biotherapeutics on August 26, 2024 and sell it today you would lose (757.00) from holding SAB Biotherapeutics or give up 70.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cyclacel Pharmaceuticals vs. SAB Biotherapeutics
Performance |
| Timeline |
| Cyclacel Pharmaceuticals |
| SAB Biotherapeutics |
Cyclacel Pharmaceuticals and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cyclacel Pharmaceuticals and SAB Biotherapeutics
The main advantage of trading using opposite Cyclacel Pharmaceuticals and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyclacel Pharmaceuticals position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Cyclacel Pharmaceuticals vs. Eliem Therapeutics | Cyclacel Pharmaceuticals vs. Ikena Oncology | Cyclacel Pharmaceuticals vs. Ovid Therapeutics | Cyclacel Pharmaceuticals vs. Connect Biopharma Holdings |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |